Tianda Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar '26 Mar 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Market Capitalization	209	277	363	469	871	501
Market Cap Growth	-41.57%	-23.67%	-22.48%	-46.17%	73.82%	15.35%
Enterprise Value	276	314	358	380	787	493
Last Close Price	0.10	0.13	0.17	0.21	0.39	0.21
Forward PE	-	6.55	6.55	6.55	6.55	6.55
PS Ratio	0.65	0.86	1.10	0.88	1.59	0.98
PB Ratio	0.46	0.61	0.72	0.79	1.33	0.64
P/TBV Ratio	0.68	0.90	0.94	0.95	1.64	0.79
P/FCF Ratio	-	-	-	-	12.69	-
P/OCF Ratio	-	-	-	-	8.55	-
EV/Sales Ratio	0.86	0.97	1.09	0.71	1.44	0.97
EV/FCF Ratio	-	-	-	-	11.47	-
Debt / Equity Ratio	0.29	0.29	0.25	0.19	0.22	0.20
Debt / EBITDA Ratio	-	-	-	20.85	-	-
Debt / FCF Ratio	-	-	-	-	2.06	-
Net Debt / Equity Ratio	0.15	0.15	0.07	-0.10	-0.34	-0.24
Net Debt / EBITDA Ratio	-2.78	-2.78	-1.46	60.10	8.04	6.46
Net Debt / FCF Ratio	-	-	-1.17	0.58	-3.27	3.09
Asset Turnover	0.43	0.43	0.39	0.53	-	0.44
Inventory Turnover	4.47	4.47	3.38	4.88	-	3.86
Quick Ratio	0.59	0.59	0.69	0.89	1.40	1.83
Current Ratio	0.83	0.83	0.86	1.10	1.54	2.13
Return on Equity (ROE)	-14.61%	-14.61%	-11.19%	-4.01%	-	-2.74%
Return on Assets (ROA)	-4.47%	-4.47%	-4.02%	-1.81%	-	-2.40%
Return on Invested Capital (ROIC)	-10.32%	-10.15%	-10.06%	-6.02%	-13.65%	-6.81%
Return on Capital Employed (ROCE)	-10.60%	-10.60%	-10.50%	-4.80%	-9.70%	-4.90%
Earnings Yield	-33.56%	-25.24%	-16.89%	-5.15%	-6.27%	-3.95%
FCF Yield	-	-	-8.34%	-21.13%	7.88%	-12.37%
Dividend Yield	-	-	-	1.22%	0.89%	1.21%
Total Shareholder Return	-	-	-	1.22%	0.89%	1.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.